Liposuction carries several potential risks, including but not limited to: Post-surgical infection, prolonged healing process, fat or blood clotting, shock, fluid accumulation excessive swelling, burns, perforations, lidocaine toxicity, fat embolism, visible blood vessels and adverse reactions to drugs or general anesthesia
Raphas Co
While GLP-1 medications are not a 'quick fix,' they can be a powerful tool for regaining momentum, reducing health risks, and supporting long-term weight management goals
Retatrutide, also known by its research name LY-3437943, is an investigational once-weekly injectable drug developed by Eli Lilly
In February 2024, top-line results from another phase II trial were released 9
10.1016/j.ddtec.2016.06.004 5 BakM